Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Use-Results Study of ILARIS Solution for S.C. Injection (Schnitzler's Syndrome)

NCT07598422 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT07598422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07598422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Use-Results Study of ILARIS Solution for S.C. Injection (Schnitzler's Syndrome)
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Recruiting
Start date
May 13, 2026
Completion date
November 25, 2032
Enrollment
10 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

schnitzler syndrome